Long-read sequencing studies found genetic alterations missed by conventional sequencing and traced the origin of a rare pediatric tumor after gene therapy ...

University of Michigan researchers used long-read nanopore sequencing to resolve hidden cancer-driving alterations in tumors ...

Ambry Genetics, a wholly owned subsidiary of Tempus AI (NASDAQ:TEM), has introduced GenomeNext and GenomeReveal, a new whole ...

Two identical sisters came into the world carrying the same rare cancer. They lost their lives to an undifferentiated sarcoma ...

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced plans to enhance its ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Whole-genome sequencing in routine care is now solving rare disease cases at scale, with ...

GeneDx (WGS) said Tuesday it plans to add long-read whole genome sequencing to its genome testing portfolio to close diagnostic gaps and deliver diagnosis faster. The company said ...

The retrospective analysis of more than 650 pediatric patients with ID/DD demonstrated that WGS identified a genetic diagnosis in 31.1% of children overall, with the diagnostic yield reaching 35.3% ...

A UKHSA-led evaluation of 61 nasopharyngeal swabs found that bait-enriched whole genome sequencing recovered an average of 85 ...

Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...

Rapid genome sequencing has proven itself in the ICU. Data from the first known study in neuro-specific pediatric inpatients suggest it may be just as valuable on the general pediatric floor.

Humans and chimpanzees share almost all their genes. Despite this, our brains have developed in different ways. Researchers ...